GTX-102, GTX/UX Diluent and Flush Solution
GTX-102-CL301
Phase 3 small_molecule active
Quick answer
GTX-102, GTX/UX Diluent and Flush Solution for Angelman Syndrome is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Angelman Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active